Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

(2022) Felix Mahfoud et al.   LANCET

Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension

(2021) Nayyra Fatani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Device Therapy of Hypertension

(2021) Felix Mahfoud et al.   CIRCULATION RESEARCH

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

(2021) Kazem Rahimi et al.   LANCET

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

(2021) David E. Kandzari et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Improving the Management of Hypertension by Tackling Awareness, Adherence, and Clinical Inertia: A Symposium Report

(2021) Atul Pathak et al.   American Journal of Cardiovascular Drugs

Cardiovascular Prognosis in Drug-Resistant Hypertension Stratified by 24-Hour Ambulatory Blood Pressure: The JAMP Study

(2021) Kazuomi Kario et al.   HYPERTENSION

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

(2020) Felix Mahfoud et al.   EUROPEAN HEART JOURNAL

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

(2020) Michael Böhm et al.   LANCET

Device-based therapies for arterial hypertension

(2020) Lucas Lauder et al.   Nature Reviews Cardiology

2020 International Society of Hypertension Global Hypertension Practice Guidelines

(2020) Thomas Unger et al.   HYPERTENSION

Renal Denervation in High-Risk Patients With Hypertension

(2020) Felix Mahfoud et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry

(2019) Felix Mahfoud et al.   EUROPEAN HEART JOURNAL

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

(2018) Maria H Mehlum et al.   EUROPEAN HEART JOURNAL

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

(2018) David E Kandzari et al.   LANCET

Time spent at blood pressure target and the risk of death and cardiovascular diseases

(2018) Sheng-Chia Chung et al.   PLoS One

Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND PatientsNovelty and Significance

(2017) Giuseppe Mancia et al.   HYPERTENSION

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

(2017) Raymond R Townsend et al.   LANCET

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension

(2015) M. Bohm et al.   HYPERTENSION

Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial

(2014) Felix Mahfoud et al.   EUROPEAN HEART JOURNAL

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry

(2013) Michael Böhm et al.   EuroIntervention